648.35
price up icon0.01%   0.86
 
loading
前日終値:
$647.49
開ける:
$647.09
24時間の取引高:
42,641
Relative Volume:
0.17
時価総額:
$39.34B
収益:
$1.86B
当期純損益:
$-40.29M
株価収益率:
-762.76
EPS:
-0.85
ネットキャッシュフロー:
$-1.28B
1週間 パフォーマンス:
+1.27%
1か月 パフォーマンス:
+0.02%
6か月 パフォーマンス:
+23.22%
1年 パフォーマンス:
+61.91%
1日の値動き範囲:
Value
$641.86
$649.91
1週間の範囲:
Value
$634.73
$649.97
52週間の値動き範囲:
Value
$349.86
$678.21

Argen X Se Adr Stock (ARGX) Company Profile

Name
名前
Argen X Se Adr
Name
セクター
Healthcare (1174)
Name
電話
-
Name
住所
-
Name
職員
1,148
Name
Twitter
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
ARGX's Discussions on Twitter

ARGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARGX
Argen X Se Adr
648.37 39.34B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
480.77 123.34B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
696.62 76.09B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.00 32.49B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
116.81 28.26B 3.30B -501.07M 1.03B -2.1146

Argen X Se Adr Stock (ARGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-17 ダウングレード Deutsche Bank Hold → Sell
2024-11-12 アップグレード Wolfe Research Peer Perform → Outperform
2024-11-05 アップグレード Scotiabank Sector Perform → Sector Outperform
2024-11-01 ダウングレード Robert W. Baird Outperform → Neutral
2024-11-01 アップグレード William Blair Mkt Perform → Outperform
2024-10-10 再開されました Raymond James Strong Buy
2024-10-04 ダウングレード Deutsche Bank Buy → Hold
2024-08-06 アップグレード Barclays Equal Weight → Overweight
2024-07-25 アップグレード Deutsche Bank Hold → Buy
2024-07-23 アップグレード Oppenheimer Perform → Outperform
2024-02-15 開始されました Wolfe Research Peer Perform
2023-12-20 ダウングレード Deutsche Bank Buy → Hold
2023-12-20 ダウングレード William Blair Outperform → Mkt Perform
2023-07-31 開始されました Scotiabank Sector Perform
2023-07-24 ダウングレード UBS Buy → Neutral
2023-07-17 再開されました Evercore ISI Outperform
2023-06-15 開始されました Societe Generale Sell
2023-05-31 開始されました UBS Buy
2023-04-25 開始されました Citigroup Buy
2023-03-14 アップグレード Robert W. Baird Neutral → Outperform
2022-12-07 開始されました William Blair Outperform
2022-10-12 開始されました Oppenheimer Perform
2022-07-29 ダウングレード Robert W. Baird Outperform → Neutral
2022-06-28 再開されました Stifel Buy
2022-05-03 アップグレード Morgan Stanley Equal-Weight → Overweight
2021-12-08 開始されました Wells Fargo Overweight
2021-11-29 アップグレード Piper Sandler Neutral → Overweight
2021-10-29 アップグレード Guggenheim Neutral → Buy
2021-10-28 アップグレード Raymond James Outperform → Strong Buy
2021-10-07 開始されました Jefferies Buy
2021-09-23 アップグレード Redburn Neutral → Buy
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-07-23 開始されました Deutsche Bank Hold
2021-07-19 再開されました Wolfe Research Outperform
2021-06-18 開始されました UBS Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-10 アップグレード H.C. Wainwright Neutral → Buy
2021-04-23 開始されました Redburn Neutral
2021-03-05 繰り返されました H.C. Wainwright Neutral
2021-02-02 ダウングレード Piper Sandler Overweight → Neutral
2021-01-04 ダウングレード Guggenheim Buy → Neutral
2020-08-25 開始されました Raymond James Outperform
2020-08-19 ダウングレード Evercore ISI Outperform → In-line
2020-07-29 開始されました H.C. Wainwright Neutral
2020-02-10 開始されました BofA/Merrill Buy
2019-11-05 開始されました Credit Suisse Neutral
2019-10-31 アップグレード William Blair Mkt Perform → Outperform
2019-10-22 開始されました JP Morgan Overweight
2019-09-27 開始されました Wells Fargo Market Perform
2019-09-16 再開されました Cowen Outperform
2019-06-28 開始されました Robert W. Baird Outperform
2019-01-18 再開されました SunTrust Buy
2019-01-04 開始されました Morgan Stanley Overweight
2018-12-17 開始されました Goldman Buy
2018-12-14 開始されました Wolfe Research Outperform
2018-06-29 開始されました Nomura Buy
2018-04-09 開始されました SunTrust Buy
2018-01-29 繰り返されました JMP Securities Mkt Outperform
すべてを表示

Argen X Se Adr (ARGX) 最新ニュース

pulisher
Feb 19, 2025

Argenx Vaults 3,659% With Profit Growth Seen In Triple Digits; Earnings Next As Stock Hits Highs - Investor's Business Daily

Feb 19, 2025
pulisher
Feb 07, 2025

BBVA Argentina ADR (BBAR) Shares Rise Despite Market Challenges - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Telecom Argentina S.A. ADR (TEO) Stock Records 32.38% Quarterly Movement - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

Guru Fundamental Report for ARGXBenjamin Graham - Nasdaq

Feb 06, 2025
pulisher
Feb 03, 2025

Orphan Designated Drugs Market Analysis: Key Trends, Players and Forecasts for Future Growth - GlobeNewswire Inc.

Feb 03, 2025
pulisher
Jan 30, 2025

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jan 30, 2025
pulisher
Jan 29, 2025

argenx SE : The stock is approaching a major resistance level -January 29, 2025 at 04:11 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 15, 2025

argenx's SWOT analysis: biotech stock soars on VYVGART success, pipeline promise - Investing.com India

Jan 15, 2025
pulisher
Jan 14, 2025

Argenx stock price target raised to $717 by H.C. Wainwright - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Jan 14, 2025
pulisher
Jan 13, 2025

Truist Securities raises argenx stock rating to Buy, says will exceed Vision 2030 - Investing.com

Jan 13, 2025
pulisher
Jan 13, 2025

Jefferies raises argenx stock target, reaffirms buy on global sales result - Investing.com

Jan 13, 2025
pulisher
Jan 07, 2025

argenx's SWOT analysis: biotech stock soars on vyvgart success - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

Piper Sandler increases argenx stock price target on revised estimates - Investing.com

Jan 07, 2025
pulisher
Jan 06, 2025

Argenx stock soars to all-time high of $645.31 amid robust growth - Investing.com

Jan 06, 2025
pulisher
Dec 28, 2024

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment - Yahoo Finance

Dec 28, 2024
pulisher
Dec 23, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 23, 2024
pulisher
Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth - Investing.com

Dec 16, 2024
pulisher
Dec 15, 2024

argenx's SWOT analysis: biotech stock soars on VYVGART success - Investing.com

Dec 15, 2024
pulisher
Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024
pulisher
Dec 09, 2024

Argenx Expands Autoimmune Portfolio With Additional Vyvgart Approvals as Pipeline Develops - Morningstar

Dec 09, 2024
pulisher
Dec 09, 2024

Piper Sandler maintains stock target on argenx, cites growth potential - Investing.com

Dec 09, 2024
pulisher
Dec 02, 2024

Argenx stock soars to all-time high of $620.29 - Investing.com

Dec 02, 2024
pulisher
Nov 30, 2024

10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey

Nov 30, 2024
pulisher
Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth By Investing.com - Investing.com South Africa

Nov 26, 2024
pulisher
Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth - Investing.com India

Nov 26, 2024
pulisher
Nov 25, 2024

argenx's SWOT analysis: biotech firm's stock soars on VYVGART success - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

Jefferies reaffirms Buy rating on argenx stock, ups target amid promising trial updates - Investing.com India

Nov 25, 2024
pulisher
Nov 21, 2024

Can Argenx stock sustain its autoimmune category dominance? Oppenheimer weighs in - Investing.com

Nov 21, 2024
pulisher
Nov 21, 2024

Barclays bullish on argenx stock after positive trial results - Investing.com

Nov 21, 2024
pulisher
Nov 21, 2024

Barclays bullish on argenx stock after positive trial results By Investing.com - Investing.com South Africa

Nov 21, 2024
pulisher
Nov 20, 2024

argenx shares see price target boosted by Raymond James, Strong Buy rating upheld - Investing.com

Nov 20, 2024
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 12, 2024

Argenx upgraded at Wolfe on myasthenia gravis dominance - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

argenx stock boosted by Wolfe, citing dominance in MG and profitability ahead - Investing.com

Nov 12, 2024
pulisher
Nov 11, 2024

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Yahoo Finance

Nov 11, 2024
pulisher
Nov 05, 2024

Scotiabank raises argenx stock PT to $715, highlights efgartigimod's potential - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

argenx SE's SWOT analysis: biotech stock poised for growth amid challenges - Investing.com

Nov 05, 2024
pulisher
Nov 04, 2024

Deutsche Bank raises argenx target by EUR25, acknowledges momentum despite valuation - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

argenx ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Nov 04, 2024
pulisher
Nov 01, 2024

Argenx shares target raised by H.C. Wainwright, citing strong sales performance - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry' - Benzinga

Nov 01, 2024

Argen X Se Adr (ARGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$252.00
price up icon 0.38%
$117.10
price down icon 0.80%
biotechnology ONC
$254.32
price up icon 3.88%
$22.90
price down icon 0.28%
$363.68
price down icon 0.48%
大文字化:     |  ボリューム (24 時間):